The company aims to “fundamentally transform cancer care,” it said, using its multi-biomarker tech platforms to detect cancer earlier than traditional tests.…

Laboratory Corporation of America Holdings, a global diagnostics company, will buy prenatal testmaker Sequenom for $371 million in cash.

Mobile app maker AnthroTronix is launching the second phase of a study that uses mobile technology to track brain issues in people who care for Alzheimer’s…

Researchers at the University of British Columbia and Switzerland’s Paul Scherrer Institut have come up with a microneedle that can painlessly measure drugs in…

Zimmer Biomet is rolling out what it calls its Signature Solutions, a package of services that includes consulting and supporting technology aimed at helping…

Royal Philips is doing alright for itself, per earnings discussed during a recent call. This boost seems to be thanks to the multitude of acquisitions Philips…

DeepMind--a Google-owned AI company--has decided to suspend use of its Streams app.

The U.K.’s Cytox announced it launched the research use of its variaTECT genetic biomarker test for assessing the risk of Alzheimer’s disease.